Role of polymers in improving the results of stenting in coronary arteries

Biomaterials

Volumn 17, Issue 7, 1996, Pages 685-694

  Peng, Tao ^a   Gibula, Paul ^b   Yao, Kang De ^c   Goosen, Mattheus F A ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c TIANJIN UNIVERSITY   (China)

^d SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Intracoronary stents; Metallic stents; Polymer paving; Polymeric stenting

Indexed keywords

BIOMATERIALS; BLOOD VESSELS; COATINGS; METALS; SURGERY;

BIODEGRADABLE STENTS; BIOSTABLE STENTS; CORONARY ARTERIES; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMER COATED STENTS; STENTING;

POLYMERS;

POLYMER;

ARTICLE; CORONARY ARTERY; PRIORITY JOURNAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030131075     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)86738-X     Document Type: Article

References (90)

1. Clark DA. Coronary Angioplasty, Wiley-Liss Inc., 1991.
2. Hearn JA, King SB, Douglas JS, Carlin SF, Lembo NJ, Ghazz IBM. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Circulation 1993; 88: 2088-2096.
3. Waller BF, Orr CM, Pinkerton CA, Van Tassel JW, Pinto RP. Morphologic observations later after coronary balloon angioplasty: mechanisms of acute injury and relationship to restenosis. Radiology 1990; 174: 961-967.
4. Colombo A, Goldberg FSL, Almagor Y, Maiello L, Finci L. A novel stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. J Am Coll Cardiol 1993; 20: 1887-1891.
5. Hanke H, Oberhoff M, Hanke S et al. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin. Circulation 1992; 85: 1548-1556.
6. Savage PM, Fischman DL, Schatz RA et al. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. J Am Coll Cardiol 1994; 24: 1207-1212.
7. Alfonso F, Hernandez R, Goicoler J. Coronary stenting for acute coronary dissection after coronary angioplasty: implications of residual dissection. J Am Coll Cardiol 1994; 24: 989-995.
8. Becker GJ. Intravascular stents: general principles and status of lower-extremity arterial applications. Circulation 1991; 83: I-122-I-136.
9. Sigwart U, Prel J, Mirkoritch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. New Engl J Med 1987; 316: 701-706.
10. Schatz RA. A view of vascular stents. Circulation 1989; 79: 445-457.
11. Serruys PW, Beatt KJ, van der Giessen WJ. Eur Heart J 1989; 10: 774-782.
12. Geore BS, Voorhees WD, Roubin GS. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993: 135-143.
13. Kimura T, Nosaka H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993; 21: 1557-1563.
14. Bar FW, van Oppen J, de Swart H et al. Percutaneous implantation of a new intracoronary stent in pigs. Am Heart J 1991; 122: 1532-1541.
15. Fischman DL, Savage MP, Leon MB et al. Fate of lesion-related side branches after coronary artery stenting. J Am Coll Cardiol 1993; 22: 1641-1646.
16. Sigwart U, Urban P, Golf S. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1988; 78: 1121-1127.
17. Yang XM, Manninen H, Matsi P, Soimakallio S. Percutaneous endovascular stenting: development, investigation and application. Eur J Radiol 1991; 13: 161-173.
18. Serruys PW, Strauss BH, van Beusekom M, van der Giessen WJ. Stenting of coronary arteries: has a modern Pandora's box been opened? J Am Coll Cardiol 1991; 17: 143B-154B.
19. Satler LF, Popma JJ, Mintz GS et al. New revascularization devices: update on coronary stents. Prim Cardiol 1993; 19: 18-30.
20. Serruys PW, Strauss BH, Beatt KT. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med 1991; 324: 13-17.
21. Garratt KN, Holmes DR. Early outcome after placement of metallic intracoronary stents: initial Mayo Clinic experience. Mayo Clin Proc 1991; 66: 268-275.
22. Serruys PW, Jaegere PD, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. New Engl J Med 1994; 331: 489-495.
23. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. New Engl J Med 1994; 331: 496-510.
24. Topol EJ. Caveats about elective coronary stenting. New Engl J Med 1994; 331: 539-541.
25. De Jaegere PP, Serruys DW, Bertrand ME. Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery. Am J Cardiol 1992; 69: 598-602.
26. Tominaga R, Kambic HE, Emoto H, Harasaki H, Sutton C, Hollman J. Effects of design geometry of intravascular endoprostheses on stenosis rate in normal rabbits. Am Heart J 1992; 123: 21.
27. Schwartz RS, Murphy JC, Edwards WD. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation 1990; 82: 2190-2200.
28. De Palma VA, Bauerre FJW, Gett VL, Furuse A. Investigation of three-surface properties of several metals and their relation to blood compatibility. J Biomed Mater Res Symp 1972; 3: 37-75.
29. Riveiro PA, Gallo R, Antonius J et al. A new expandable intracoronary tantalum (Strecker) stent: early experimental results and follow-up to twelve months. Am Heart J 1993; 125: 501-510.
30. Palmax JC. Intravascular stents: tissue-stent interactions and design considerations. Am J Radiol 1993; 160: 613-618.
31. Agrawal CM, Haas KF, Leopold DA, Clark HG. Evaluation of poly(L-lactic acid) as material for intravascular polymeric stents. Biomaterials 1992; 13: 176-182.
32. Zdrahala RJ. Absorbable poly(alpha ester) materials for temporary endovascular stenting in balloon angioplasty (PTCA). The 16th Annual Meeting of the Society of Biomaterials 20-23 May 1990: 155.
33. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 1989; 80: 1347-1353.
34. van der Giessen WJ, van Beusekon HMN, van Howten CD, van Woerkens LJ, Verdouvo PD, Serruys PW. Coronary stenting with polymer coated and uncoated self-expanding endoprostheses in pigs. Cor Art Dis 1992; 3: 631-640.
35. Schlarsky-Goldberg RD, LeVeen RF, Hillstead RA, Lope C. Temporary vascular stenting (abstr.). Radiology 1990; 177: 299.
36. Khorsandi MJ, Eigler NL, Hess RL, Lallister JP, Forrester JS, Litvack F. Implantation and recovery of balloon delivered removable stent (abstr.). J Am Coll Cardiol 1992; 19: 218A.
37. Gaspard PE, Didier BP, Delsanti GL. The temporary stent catheter: a non-operative treatment for acute occlusion during coronary angioplasty (abstr.), J Am Coll Cardiol 1991; 15: 118A.
38. Holmes DR, Camrud AR, Jorgenson MA, Edwards WD, Schwartz RS. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J Am Coll Cardiol 1994; 24: 525-531.
39. Blengino S, Maielo L, Hall P, Nakamura S, Giovanni M, Colombo A. Randomized trial of coronary stent implantation without anticoagulation aspirin vs. ticlopidine. Circulation 1994; 90: I-24.
40. Jordan C, Carvalho H, Fajadet J, Bernard C, Robert G, Marco J. Reduction of subacute thrombosis rate after coronary stenting using a new anticoagulant protocol. Circulation 1994; 90: I-25.
41. Yoshioka T, Mirich D, Wright KC, Wallace S. Self-expanding endovascular graft: an experimental study in dogs. Am J Radiol 1988; 15: 673-676.
42. Roeren T, Garcia OJ, Palmaz JC, Rees CR, Tio FO. Intraarterial compatibility of a balloon-expandable tubular graft. Radiology 1990; 174: 1069.
43. De Scheerder IK, Wilczek KF, Verbeken E et al. Amphiphilic polyurethane coating of intracoronary stents decreases mortality due to subacute thrombosis in a porcine coronary model. J Am Coll Cardiol 1994; 23: 186A.
44. Sheth S, Park KD, Dev V et al. Prevention of stent subacute thrombosis by segmented polyurethane-polyethylene oxide-heparin coating in the rabbit carotid. Am J Coll Cardiol 1994; 23: 187A.
45. Schwartz RS, Huber KC, Edwards WD et al. Native fibrin film as a biocompatible, absorbable material for intracoronary stent implant and drug delivery. J Am Coll Cardiol 1992; 19: 171A.
46. de Jaegere PPT. Endovascular stents: preliminary clinical results and future developments. Clin Cardiol 1993; 16: 369-378.
47. Lincoff AM, Furst JG, Ellis SG, Topol EJ. Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery. J Am Coll Cardiol 1994; 23: 18A.
48. Eigler NL, Lambert TL, Dev V et al. Local arterial wall drug delivery from a polymer coated removable metallic stent: kinetics, distribution and bioactivity of forskolin. J Am Coll Cardiol 1994; 23: 4A.
49. Hastings GW, ed. Cardiovascular Biomaterials. London: Springer-Verlag, 1992.
50. Murphy JG, Schwartz RS, Huber KC, Holmes DR. Polymeric stents: modern alchemy or the future? J Invasive Cardiol 1991; 3: 144-148.
51. Szycher M, Lee SJ. Cardiovascular device for the 1990s. J Biomater Appl 1993; 8: 31-63.
52. Devanathan TD. Silicone elastomers for implantable biomedical devices. In: Szycher M, ed. Biocompatible Polymers, Metals and Composites. Technomic Publishing Co. Inc., 1983: 769.
53. Hinrichs WLJ, Zweep HP, Satoh S, Feijen J, Wildevaur ChRH. Supporting microsporous elastomeric, degradable prostheses to improve the arterialization of autologous vein grafts. Biomaterials 1994; 15: 83-91.
54. Porter J, Ahsan A, Mulcahy D, Sigwart U. Coronary stents. Br J Hosp Med 1992; 47: 411-419.
55. Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vliletstra RE, Holmes DR. Percutaneous polymeric stents in porcine coronary arteries: initial experience with polyethylene terephthalate stents. Circulation 1992; 86: 1596-1604.
56. Harasaki H, Kiraly RJ, Nose Y. Blood-blood pump surface interaction. In: Szycher M, ed. Biocompatible Polymers, Metals and Composites. Technomic Publishing Co. Inc., 1993: 208.
57. Schwartz RS, Huber KL, Murphy JG et al. Restenosis and the proportional neointimal response to coronary artery. J Am Coll Cardiol 1992; 19: 267-274.
58. Mitchel JF, Azrin MA, Fram DB et al. Intramural deposition of urokinase at the angioplasty site - Comparative efficiency of systemic and local drug delivery techniques. Circulation 1994; 90: I-20.
59. Thomas CN, Robinson KA, Cipolla GD, Jones M, King SB, Scott NA. In vivo local delivery of heparin to coronary arteries with a microsporous infusion catheter. J Am Coll Cardiol 1994; 23: 187A.
60. Thomas CN, Barry JJ, King SB, Scott NA. Local delivery of Heparin with a PTCT infusion balloon inhibits platelet-dependent thrombosis. J Am Coll Cardiol 1994; 23: 4A.
61. Jenkins GM, Leong K, Heller P et al. Local delivery of taxol inhibits neointimal regrowth following balloon injury of the rat carotid artery. Circulation 1994; 90: I-297.
62. Meyer B, Fernandez-Ortiz F, Fuster V et al. Local delivery of γ-hirudin by a double balloon perfusion catheter inhibits platelet deposition post angioplasty. J Am Coll Cardiol 1994; 23: 18A.
63. Slepian MJ, Massia SP. Local delivery of a YIGSR peptide inhibits neointimal hyperplasia following balloon injury. Circulation 1994; 90: I-297.
64. Rfng EJ, Schwarz W, McLean GK, Freiman A. A simple, indwelling, biliary endoprosthesis made from commonly available catheter material. Am J Radiol 1982; 139: 615-619.
65. Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-1492.
66. Shaper NJ, Rutt DR, Browse NL. Use of Teflon stents for lymphovenous anastomosis. Br J Surg 1992; 79: 633-636.
67. Kemppainen E, Taija M, Riihela M, Pohjonen T, Tormala P, Alfthan O. A bioresorbable urethral stent. Urol Res 1993; 21: 235-238.
68. Goldberg JR. Biodegradable stents. European Patent 0420541 A2.
69. Rothman M, Davies SW. Br Heart J 1992; 67: 425-427.
70. Duprat G, Wright KC, Charnsangavej C, Wallace S, Gianturco C. Self-expanding metallic stents for small vessels: an experimental evaluation. Radiology 1987; 162: 469-472.
71. Murphy JG, Schwartz RS, Kennedy K et al. A new biocompatible polymeric coronary stent: design and early results in a pig model. J Am Coll Cardiol 1990; 15: 105A.
72. Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Experimental coronary artery stenosis induced by polymer (PET) implantation in domestic swine. J Am Coll Cardiol 1991; 17: 195B.
73. van der Giessen WJ, Slager CJ, Gussenhoven EJ et al. Mechanical features and in vivo imaging of a polymer stent. Intern J Cardiac Imaging 1993; 9: 219-226.
74. van der Giessen WJ, Slager CJ, van Beusekom HMM et al. Mechanical features and in vivo behaviour of a polymer stent. J Am Coll Cardiol 1992; 19: 49A.
75. Zhang XC. Biodegradable lactide polymers: synthesis, degradation and drug controlled release properties. PhD thesis. Kingston, Canada: Queen's University, 1993.
76. Agrawal CM, Clark HG. Deformation characteristics of a bioabsorbable intravascular stent. Invest Radiol 1992; 27: 1020-1024.
77. Chapman GD, Gammon RS, Bauman RP et al. A bioabsorbable stent: initial experimental results. Circulation 1990; 82: III-72.
78. Beck A. Uber eine neue ballonexpandierbare kunststoffendoprosthese: erster erfahrungsbericht uber den modellierbaren thermostent. Radiologe 1990; 30: 347-350.
79. Eury RP. Multilayered biodegradable stent and method for its manufacture. European Patent 604022 A1.
80. Lincoff AM, Schwartz RS, van der Giessen WJ et al. Biodegradable polymer can evoke a unique inflammatory response when implanted in the coronary artery. Circulation 1992; 86: I-801.
81. in't Veld PJ, Dijkstra PJ, Feijen J. Synthesis of biodegradable polyesteramides with pendant functional groups. Makromol Chem 1992; 193: 2713-2730.
82. Barrera DA, Iylstra E, Lansbury PT, Langer R. Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine). J Am Chem Soc 1993; 115: 11010-11011.
83. Hrkach JS, Ou J, Langer R. The development of poly(L-lactic acid-co-L-lysine) for tissue engineering: functionalization and new monomer synthesis. Polym Preprint 1994; 35(2): 450-451.
84. Slepian MJ, Massia SP. Local delivery of a cyclic RGD peptide inhibits neointimal hyperplasia following balloon injury. Circulation 1993; 88: I-372.
85. Minra Y. Antithrombogenic biomedical materials improved by enzyme immobilization technique. In: Szycher M, ed. Biocompatible Polymers, Metals, and Composites. Technomic Publishing Co. Inc., 1983: 301.
86. Slepian MJ, Schindler A. Polymeric endoluminal paving/sealing: a biodegradable alternative to intracoronary stenting. Circulation 1988; 78: II-409.
87. West HJL, Chowdhury SM, Slepian MJ, Hubbell JA. The hydrogel barriers for prevention of thrombosis and intimal thickening after balloon injury. J Am Coll Cardiol 1994; 24: 5A.
88. Slepian MJ, Campbell PK, Berrigan K et al. Biodegradable endoluminal polymer layers provide sustained transmural heparin delivery to the arterial wall in vivo. Circulation 1994; 90: I-20.
89. Hill West JL, Chowdhury SM, Slepian MJ, Hubbell JA. Resorbable hydrogel barriers for controlling intravascular thrombosis and healing. Polym Preprint 1994; 35(2): 396-398.
90. Slepian MJ, Massia SP, Sawhney A. Endoluminal gel paving using in situ biodegradable photopolymerized hydrogel: acute efficacy in the rabbit. Circulation 1993; 88: I-660.